Cytel: Albert Kim, chief medical officer
Clinical trial software company Cytel has appointed Albert Kim to serve as its first chief medical officer. Kim brings more than 21 years of diverse experience at a range of companies, including roles at Novartis and Pfizer.
“Innumerable challenges can hinder clinical development success, not least the potential communications gaps between statisticians and clinicians,” said Joshua Schultz, CEO of Cytel. “Empowering and connecting teams that speak different scientific languages makes navigating hurdles in clinical research dramatically more efficient. Dr Kim, with his multi-domain expertise, will be an accelerating force as Cytel expands our application of advanced analytics to the entire product development team — from patient recruitment to market access.”
